SCIENCE NEWS Tiny RNA Shown to Cause Multiple Types of Leukemia Whitehead Institute researchers have shown in mouse models that overexpression of the microRNA 125b (miR-125b) can independently cause leukemia and accelerate the disease’s progression. [Press release from the Whitehead Institute for Biomedical Research discussing online prepublication in the Proceedings of the National Academy of Sciences USA] Study Identifies Potential Mechanism of Drug Resistance of CLL in Bone Marrow and Lymph Nodes Investigators offer a new explanation of why chronic lymphocytic leukemia (CLL) tends to recur in the lymph nodes and bone marrow after being cleared from the bloodstream by chemotherapy. [Press release from the Dana-Farber Cancer Institute discussing data presented at the 52nd Annual Meeting of the American Society of Hematology (ASH)] Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML A new drug appears to help chronic myeloid leukemia (CML) patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from the start, researchers reported. [Press release from the MD Anderson Cancer Center discussing data presented at the 52nd Annual Meeting of the American Society of Hematology (ASH)] First Results from Phase II Study of Fractionated Radioimmunotherapy with Y-90 Epratuzumab in Aggressive Lymphoma Presented at Hematology Conference Immunomedics, Inc., reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP chemotherapy, improved remission status of adult patients with diffuse large B cell lymphoma, a form of aggressive lymphoma. [Press release from Immunomedics, Inc. discussing data presented at the 52nd Annual Meeting of the American Society of Hematology (ASH)]
|
|
LABORATORY RESEARCH Allogeneic Effector/Memory Th-1 Cells Impair FoxP3+ Regulatory T Lymphocytes and Synergize with Chaperone-Rich Cell Lysate Vaccine to Treat Leukemia Here, researchers demonstrate that effector/memory CD4+ T helper-1 (Th-1) lymphocytes, in addition to polarizing type-1 anti-tumor immune responses, impair tumor-induced CD4+CD25+FoxP3+ regulatory T cell immunosuppressive function in vitro and in vivo. [Blood] MicroRNA-125b Expands Hematopoietic Stem Cells and Enriches for the Lymphoid-Balanced and Lymphoid-Biased Subsets Here, researchers show that microRNA-125b (miR-125b) is highly expressed in hematopoietic stem cells and its expression decreases in committed progenitors. [Proc Natl Acad Sci USA] As4S4 Targets RING-Type E3 Ligase c-CBL to Induce Degradation of BCR-ABL in Chronic Myelogenous Leukemia Arsenic, a curative agent for acute promyelocytic leukemia, induces cell apoptosis and degradation of BCR-ABL in chronic myelogenous leukemia (CML). Researchers demonstrated that ubiquitination and degradation of BCR-ABL was mediated by c-CBL, a RING-type E3 ligase that was also shown to be involved in ubiquitination for many other receptor/protein tyrosine kinases. [Proc Natl Acad Sci USA] MicroRNA miR-125b Causes Leukemia Researchers show that overexpression of miR-125b is sufficient both to shorten the latency of BCR-ABL-induced leukemia and to independently induce leukemia in a mouse model. [Proc Natl Acad Sci USA] BCR/ABL Stimulates WRN to Promote Survival and Genomic Instability In summary, researchers postulate that BCR/ABL-mediated stimulation of WRN modulates the efficiency and fidelity of major DNA double-strand break repair mechanisms to protect leukemia cells from apoptosis and to facilitate genomic instability. [Cancer Res] CLINICAL RESEARCH Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydroxyglutarate production. Mutational and epigenetic profiling of a large acute myeloid leukemia (AML) patient cohort revealed that IDH1/2-mutant AMLs display global DNA hypermethylation and a specific hypermethylation signature. [Cancer Cell] HLA-Matched Sibling Bone Marrow Transplantation for Beta-Thalassemia Major Researchers describe outcomes after HLA-matched sibling bone marrow transplantation (BMT) for 179 patients with beta-thalassemia major. [Blood] Rituximab-Cyclophosphamide-Dexamethasone Combination in the Management of Autoimmune Cytopenias Associated with Chronic Lymphocytic Leukemia Researchers report their experience on rituximab-cyclophosphamide-dexamethasone (RCD) combination therapy for the treatment of autoimmune disorders (AIDs) in 48 chronic lymphocytic leukemia (CLL) patients. [Leukemia] Inhibition of STAT5 by the Inhibitor of Janus Kinases Stimulates Dormant Human Leukemia CD34+/CD38- Cells and Sensitizes Them to Anti-Leukemia Agents To verify molecular mechanisms by which leukemia stem cells (LSCs) maintain a dormant state, researchers explored the activity of the major pro-survival signal pathways in CD34+/CD38- compartment, supposed to contain LSCs, and CD34+/CD38+ counterparts from patients with acute myelogenous leukemia (AML, n=11) by fluorescence-activated cell sorting. [Int J Cancer]
|
|
EVENTS (Listed by Date) The 3rd Guangzhou International Conference on Stem Cell Biology and Regenerative Medicine December 17-19, 2010 Guangzhou, China Highlights of American Society of Hematology (ASH) Vancouver January 21-22, 2011 Vancouver, Canada Highlights of American Society of Hematology (ASH) Washington, D.C. January 28-29, 2011 Washington, D.C., United States Highlights of American Society of Hematology (ASH) San Francisco January 28-29, 2011 San Francisco, United States Highlights of American Society of Hematology (ASH) New York February 4-5, 2011 New York, United States Highlights of American Society of Hematology (ASH) San Diego February 4-5, 2011 San Diego, United States BMT Tandem Meetings (ASBMT/CIBMTR) February 17-21, 2011 Honolulu, Hawaii Molecular Medicine Tri-Conference: Inaugural Circulating Tumor Cells for Cancer Detection, Diagnosis, Prognosis and Treatment February 23-25, 2011 San Francisco, United States Cell Culture World Congress 2011 – Optimising Cell Culture Development for Biopharmaceutical, Bioprocessing and Manufacture February 28-March 2, 2011 Munich, Germany American Association for Cancer Research (AACR) Stem Cells, Development, and Cancer March 3-6, 2011 Vancouver, Canada PITTCON Conference & Expo 2011 March 13-18, 2011 Atlanta, United States Keystone Symposia: Hematopoiesis March 27-April 1, 2011 Big Sky, United States United Kingdom National Stem Cell Network 2011 Annual Scientific Conference March 30-April 1, 2011 York, United Kingdom American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 April 2-6, 2011 Orlando, United States 37th Annual Meeting of the European Group for Blood and Marrow Transplantation April 3-6, 2011 Paris, France World Stem Cells & Regenerative Medicine Congress 2011 May 9-11, 2011 London, United Kingdom International Society for Stem Cell Research (ISSCR) 9th Annual Meeting June 15-18, 2011 Toronto, Canada Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community. JOB OPPORTUNITIES Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies) Lab Technologist – Tissue Culture (STEMCELL Technologies) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost. Visit here to post your career opportunities.
Have we missed an important article or publication in Hematopoiesis News? Click here to submit! Comments or Suggestions? Email info@connexoncreative.com with your feedback.
|
| |
|